Las Vegas - Though Medicare reform is the hostage of legislative gridlock, and tort reform is the victim of pre-election year inertia, American Academy of Dermatology President Raymond L. Cornelison Jr., M.D., has at least one piece of positive news for dermatologists. According to Dr. Cornelison, the AAD's recently formed Ad Hoc Task Force on Skin Care for Developing Countries, in conjunction with the Centers for Disease Control (CDC), in Haiti has begun an initiative providing for volunteer dermatologists to train primary care givers to treat filoriasis.
Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
The FDA approval, based on 36-week data from the phase 3 BRAVE-AA-PEDS trial, extends baricitinib access to patients as young as 12 years old with severe alopecia areata.
Three experimental hair loss mechanisms are moving through late-stage trials for the first time in decades, and the data are worth knowing before patients ask.